ArticleFrontiers in psychiatry2025
Effects of neuroticism on suicide risk in major depressive disorder and bipolar disorder.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Suicide is the primary cause of death in patients with major depressive disorder (MDD) or bipolar disorder (BD). Among various personality traits, neuroticism is particularly relevant to suicide risk. However, its role in MDD and BD has not been examined sufficiently. This study characterized neuroticism in patients with MDD or BD, and analyzed the association between neuroticism and suicide risk in these patients. Methods: This study collected demographic information and personality traits of MDD and BD patients. Group differences were assessed using t-tests, chi-square tests, and Mann-Whitney U tests. To identify factors associated with suicide risk, correlation analysis was first conducted, followed by bivariate and generalized ordered logistic regression for significant variables, including neuroticism. Sensitivity analyses were performed by progressively excluding potential confounders to evaluate the robustness of neuroticism's effect. Additionally, simple mediation analyses using a bootstrap approach were conducted to examine whether depressive symptoms mediated the association between neuroticism and suicide risk in MDD and BD separately. A two-tailed Results: The study population comprised 88 MDD patients and 90 BD patients. Lifetime suicide risk was present in 39.3% of the study population. In the entire sample, neuroticism was significantly associated with both lifetime ( Conclusion: Neuroticism plays a significant role in influencing suicide risk among MDD and BD, through its effect on depressive symptoms. Interventions for neuroticism can reduce depressive symptoms and suicide risk. This highlights the necessity of identification and management of neuroticism in suicide prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.